BioArctic AB (BRCTF) reports significant royalty growth and strategic advancements amid revenue challenges and rising R&D expenses.
Regulators are reviewing what could become a multi-billion-dollar drug.
Worldwide Healthcare Trust PLC - Half-year Report PR Newswire LONDON, United Kingdom, November 15 LONDON STOCK EXCHANGE ANNOUNCEMENTWorldwide Healthcare Trust PLCUnaudited ...